vorinostat has been researched along with Aura in 3 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Epilepsy is a spectrum of neurological disorders with many causal factors." | 1.46 | Inhibitory synapse deficits caused by familial α1 GABA ( Chen, X; Durisic, N; Keramidas, A; Lynch, JW, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Lunke, S | 1 |
| Maxwell, S | 1 |
| Khurana, I | 1 |
| K N, H | 1 |
| Okabe, J | 1 |
| Al-Hasani, K | 1 |
| El-Osta, A | 1 |
| Chen, X | 1 |
| Durisic, N | 1 |
| Lynch, JW | 1 |
| Keramidas, A | 1 |
| Di, XJ | 1 |
| Han, DY | 1 |
| Wang, YJ | 1 |
| Chance, MR | 1 |
| Mu, TW | 1 |
3 other studies available for vorinostat and Aura
| Article | Year |
|---|---|
Epigenetic evidence of an Ac/Dc axis by VPA and SAHA.
Topics: Acetylation; Cells, Cultured; Epigenesis, Genetic; Epilepsy; Gene Expression Regulation; Histone Dea | 2021 |
Inhibitory synapse deficits caused by familial α1 GABA
Topics: Animals; Anticonvulsants; Carbamazepine; Cerebral Cortex; Coculture Techniques; Epilepsy; HEK293 Cel | 2017 |
SAHA enhances Proteostasis of epilepsy-associated α1(A322D)β2γ2 GABA(A) receptors.
Topics: Calnexin; Epilepsy; gamma-Aminobutyric Acid; HEK293 Cells; Histone Deacetylase Inhibitors; Humans; H | 2013 |